Element Biosciences
- 12/07/2024
- Series D
- $277,000,000
Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multiomics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.
- Industry Biotechnology Research
- Website https://www.elementbiosciences.com/
- LinkedIn https://www.linkedin.com/company/elembio/
Related People
Molly HeFounder
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. The Company's technology will broaden the end user experience through improved data quality and simplified workflows to benefit discoveries and diagnosis in healthcare.
At Foresite, we invest in some of the most exciting and innovative companies in healthcare.